title: PCSK9: is it fluoride for cardiology?
authors.forename: Spencer B
authors.initials: SB
authors.lastname: King
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002309:Cardiology / Q000639:trends*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control* / Q000601:surgery; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D058990:Molecular Targeted Therapy; D062645:Percutaneous Coronary Intervention / Q000639:trends*; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D012697:Serine Endopeptidases / Q000276:immunology / Q000378:metabolism; D019564:Unnecessary Procedures
chemical_list: D000911:Antibodies, Monoclonal; D000960:Hypolipidemic Agents; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases